• Home
  • Search Results
  • Sirt1 induction confers resistance to etoposide-induced genotoxic apoptosis in thyroid cancers.

Sirt1 induction confers resistance to etoposide-induced genotoxic apoptosis in thyroid cancers.

International journal of oncology (2014-08-12)
Ki Hwan Kweon, Cho Rok Lee, Soo Jung Jung, Eun Jeong Ban, Sang-Wook Kang, Jong Ju Jeong, Kee-Hyun Nam, Young Suk Jo, Jandee Lee, Woong Youn Chung
ABSTRACT

Despite the favorable therapeutic outcomes reported in differentiated thyroid cancer (DTC), a significant proportion of DTC patients present with refractory behavior to conventional therapy. The sirtuin (Sirt) family has recently been implicated in the maintenance of cellular homeostasis under genotoxic stress. Here, we investigated the induction of Sirt1 expression by etoposide-induced genotoxic stress to gain insights into thyroid carcinogenesis and identify novel therapeutic targets. Immunohistochemical staining analyses of Sirt1 and Sirt3 were performed using human thyroid cancer tissues and matched normal tissues, and bioinformatic analyses were done using public repositories, including the Human Protein Atlas, BioGPS, NCBI Gene Expression Omnibus (GEO) profiles, and GeneNetwork. TPC1, FTC133 and FRO cells were used for molecular biological experiments including apoptosis assays, MTT, immunofluorescence staining and qRT-PCR assays. The IHC data and public repositories data consistently showed variable Sirt1 and Sirt3 expression patterns in normal thyroid follicular cells and papillary thyroid cancer cells. The induction of Sirt1 and Sirt3 was cell type-specific and the expression levels of these genes correlated with apoptotic cell death and cell viability after etoposide-induced genotoxic stress. Sirt1‑Foxp3 signaling-mediated regulation of Bax and p21 mRNA expression was a signature molecular event in TPC1 cells, which showed remarkable resistance to etoposide-induced genotoxic stress. The induction of Sirt1 and Sirt3 may be a determinant of thyroid cancer cell survival under genotoxic stress conditions. Further examination of the Sirt1-Foxp3 signal may improve our understanding of thyroid carcinogenesis and help identify new druggable targets.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Etoposide, synthetic, 98.0-105.0%, powder
Sigma-Aldrich
Monoclonal Anti-KRAS antibody produced in mouse, clone 3B10-2F2, purified immunoglobulin, buffered aqueous solution
Etoposide, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Monoclonal Anti-KRAS antibody produced in mouse, clone 4F3, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
Anti-KRAS antibody, Mouse monoclonal, clone KRAS-A582, purified from hybridoma cell culture
Sigma-Aldrich
Anti-KRAS antibody produced in rabbit, affinity isolated antibody
Sigma-Aldrich
Anti-NSG1 antibody produced in rabbit, affinity isolated antibody
Sigma-Aldrich
Monoclonal Anti-D4S234E antibody produced in mouse, clone 1C3, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
Anti-KRAS antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
Etoposide for system suitability, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Anti-KRAS antibody produced in rabbit, affinity isolated antibody
Sigma-Aldrich
Monoclonal Anti-c-K-Ras antibody produced in mouse, clone 234-4.2, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
Anti-NS3 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution